NCT01168713: Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia |
|
|
| Completed | 2 | 132 | US, Canada | Levofloxacin, Levaquin, CEM-101, Solithromycin | Melinta Therapeutics, Inc. | Community-Acquired Bacterial Pneumonia | 07/11 | 07/11 | | |
NCT01591447: Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea |
|
|
| Completed | 2 | 60 | US | solithromycin, Solithromycin (CEM-101) | Melinta Therapeutics, Inc. | Uncomplicated Urogenital Gonorrhea | 06/13 | 06/13 | | |
